NCT04782544View on ClinicalTrials.gov

Ganglioside and IBD

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 28, 2021

Primary Completion Date

September 15, 2023

Study Completion Date

March 24, 2024

Conditions
Inflammatory Bowel Diseases
Interventions
OTHER

Buttermilk Powder

Treatment with 5.0 g of buttermilk powder daily for 10 weeks.

OTHER

Anhydrous Milk Fat

Treatment with 5.0 g of milk powder (90% anhydrous milk fat, 10% buttermilk powder) daily for 10 weeks.

Trial Locations (1)

92868

Children's Hospital of Orange County, Orange

All Listed Sponsors
lead

Children's Hospital of Orange County

OTHER